Boston Trust Walden Corp Sells 3,100 Shares of CVS Health Co. (NYSE:CVS)

Boston Trust Walden Corp cut its holdings in CVS Health Co. (NYSE:CVS) by 14.4% in the third quarter, HoldingsChannel reports. The firm owned 18,485 shares of the pharmacy operator’s stock after selling 3,100 shares during the quarter. Boston Trust Walden Corp’s holdings in CVS Health were worth $1,162,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in CVS. Pathway Financial Advisers LLC lifted its holdings in shares of CVS Health by 5,864.2% in the 3rd quarter. Pathway Financial Advisers LLC now owns 1,730,343 shares of the pharmacy operator’s stock valued at $108,804,000 after acquiring an additional 1,701,331 shares during the last quarter. Forsta AP Fonden raised its stake in shares of CVS Health by 9.4% during the third quarter. Forsta AP Fonden now owns 343,000 shares of the pharmacy operator’s stock valued at $21,568,000 after acquiring an additional 29,500 shares in the last quarter. Allworth Financial LP raised its stake in shares of CVS Health by 10.7% during the third quarter. Allworth Financial LP now owns 17,613 shares of the pharmacy operator’s stock valued at $1,108,000 after acquiring an additional 1,706 shares in the last quarter. Joel Isaacson & Co. LLC raised its stake in shares of CVS Health by 57.6% during the third quarter. Joel Isaacson & Co. LLC now owns 5,473 shares of the pharmacy operator’s stock valued at $344,000 after acquiring an additional 2,000 shares in the last quarter. Finally, Cullinan Associates Inc. raised its stake in shares of CVS Health by 43.8% during the third quarter. Cullinan Associates Inc. now owns 122,682 shares of the pharmacy operator’s stock valued at $7,125,000 after acquiring an additional 37,395 shares in the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on CVS. TD Cowen raised shares of CVS Health from a “hold” rating to a “buy” rating and lifted their price objective for the company from $59.00 to $85.00 in a report on Friday, October 4th. Deutsche Bank Aktiengesellschaft cut their price objective on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a report on Friday, August 9th. Mizuho cut their price objective on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a report on Thursday. Truist Financial lifted their price objective on shares of CVS Health from $66.00 to $76.00 and gave the company a “buy” rating in a report on Friday, October 11th. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $68.00 price objective on shares of CVS Health in a report on Wednesday, September 4th. Nine equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $74.58.

CVS Health Price Performance

Shares of CVS opened at $56.49 on Monday. The firm has a market capitalization of $70.92 billion, a PE ratio of 9.93, a price-to-earnings-growth ratio of 0.84 and a beta of 0.54. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66. CVS Health Co. has a 1-year low of $52.77 and a 1-year high of $83.25. The company’s fifty day moving average price is $59.82 and its 200-day moving average price is $59.84.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.73 by $0.10. The company had revenue of $91.23 billion during the quarter, compared to the consensus estimate of $91.41 billion. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The firm’s quarterly revenue was up 2.6% on a year-over-year basis. During the same period in the previous year, the firm posted $2.21 earnings per share. On average, equities research analysts predict that CVS Health Co. will post 6.41 EPS for the current year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Monday, October 21st will be given a dividend of $0.665 per share. The ex-dividend date of this dividend is Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a yield of 4.71%. CVS Health’s dividend payout ratio is presently 46.75%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.